Purchase this article with an account.
D. E. Baranano, S. J. Kim, H. F. Edelhauser, U. B. Kompella, C. Durairaj, J. T. Handa; Efficacy and Pharmacokinetics of Intraocular Ketorolac and Diclofenac. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5606.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To determine the efficacy and pharmacokinetics of intravitreally delivered nonsteroidal anti-inflammatory drugs (NSAID) in a rabbit model of panuveitis.
Lipopolysaccharide was injected into the vitreous of rabbit eyes as an experimental model of panuveitis. Treated eyes were injected with 3 mg of ketorolac or 0.3 mg of diclofenac (0.05 ml.) Twenty-four hours later, aqueous and vitreous was sampled. Total leukocyte concentration was determined by hemocytometer. Protein concentration was determined by Bradford assay. Prostaglandin concentration was determined by enzyme-linked immunoassay. For intraocular pharmaocokinetics, 0.1 ml of ketorolac (3 mg) and 0.1 ml of diclofenac (0.3 mg) were injected into eyes of rabbits. At 0.15, 1, 2, 4, 24, and 48 hours after injection, eyes were snap frozen in liquid nitrogen and the vitreous and retina/choroid were later isolated. Reverse-phase high performance liquid chromatography was used for analysis.
Eyes treated with ketorolac and diclofenac demonstrated aqueous leukocyte concentrations that were reduced 72% and 74% respectively compared to untreated controls (p<0.05.) Both aqueous and vitreous prostaglandin E2 concentrations were markedly reduced in ketorolac and diclofenac treated eyes compared to untreated eyes. Vitreous concentration of ketorolac peaked at 0.15 minutes at 234 µg/ml and peaked for diclofenac at 1 hour at 15 µg/ml. After 48 hours, ketorolac was still detectable with a concentration of 0.06 µg/ml, while diclofenac was undetectable after 24 hours. The concentration of each drug in the retina/choroid was 201 µg/g for ketorolac and 4 µg/g for diclofenac after 0.15 hours, and peaked at 280 µg/g after 2 hours and 4 µg/g after 1 hour, respectively. Both drugs were undetectable in the retina/choroid after 48 hour.
Both ketorolac and diclofenac were found to have potent anti-inflammatory effects when delivered intravitreally. Pharmacokinetic analysis demonstrated good penetration into the retina/choroid and rapid clearance by 48 hours. Future studies evaluating these intraocular NSAIDs in animal models of macular edema will be useful.
This PDF is available to Subscribers Only